HutchMED (China) LIMITED Payments to Acquire Short-term Investments
HutchMED (China) LIMITED (HMDCF) reported Payments to Acquire Short-term Investments of $2.74 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-03-05
- HutchMED (China) LIMITED payments to acquire short-term investments for the quarter ending 2019-12-31 was $51.45M, a 76.05% decline year-over-year.
- HutchMED (China) LIMITED payments to acquire short-term investments for the quarter ending 2019-09-30 was $97.59M, a 50.62% decline year-over-year.
- HutchMED (China) LIMITED payments to acquire short-term investments for the quarter ending 2019-06-30 was $153.93M, a 37.72% decline year-over-year.
- HutchMED (China) LIMITED payments to acquire short-term investments for the quarter ending 2019-03-31 was $175.17M, a 28.21% decline year-over-year.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.74B 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $1.30B 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $1.85B 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $991.06M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $1.63B 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $835.09M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $1.20B 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $578.60M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $1.36B 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $412.96M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $732.91M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $422.84M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $51.45M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $149.04M derived: sum of 2 quarters · filed 2022-03-03 | $302.97M derived: sum of 3 quarters · filed 2022-03-03 | $478.14M 20-F · filed 2022-03-03 |
| 2019-09-30 | $97.59M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $251.52M derived: sum of 2 quarters · filed 2020-07-30 | $426.69M 6-K · filed 2020-01-21 | $641.46M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $153.93M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $329.10M 6-K · filed 2020-07-30 | $543.87M derived: sum of 3 quarters · filed 2021-03-04 | $741.48M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $175.17M 6-K · filed 2019-06-06 | $389.94M derived: sum of 2 quarters · filed 2021-03-04 | $587.56M derived: sum of 3 quarters · filed 2021-03-04 | $834.72M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $214.76M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $412.38M derived: sum of 2 quarters · filed 2021-03-04 | $659.55M derived: sum of 3 quarters · filed 2021-03-04 | $903.55M 20-F · filed 2021-03-04 |
| 2018-09-30 | $197.62M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $444.78M derived: sum of 2 quarters · filed 2020-01-21 | $688.79M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $247.16M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $491.17M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $244.00M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $325.03M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $16.00M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $80.86M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $46.59M 6-K · filed 2017-07-31 |